Selection to Launch Drug Lifecycle App

The client was searching for a strategic implementation partner who could quicken the process of its digital transformation. Indium was assigned to digitise the client’s core production activities from product ideation to launch, improve operational efficiency, and assist in the swift introduction of new products to the market as a top provider of digital engineering services and a global Mendix Services leader.

The client is a leading multinational pharmaceutical company that serves over half a billion patients worldwide today and aims to triple that by 2030. With a focus on major therapeutic areas, they offer a vast portfolio of products and services including 190 medications, 60 active pharmaceutical ingredients (APIs), custom pharmaceutical services, generics, biosimilars, diagnostic kits, critical care, biotechnology products among others. They are a key player in manufacturing a prominent covid-19 vaccine

• Build a pervasive cross-functional interface that would digitize and transform the Selection to Launch (S2L) process through delightful user experience, enhanced visibility, and provisions to foster cross-functional collaboration
• Create specific reports, Gantt charts and dashboards for each product
• Setup digital alerts & notifications to intimate the user about their tasks. Enable the dashboard to perform advanced analytics using digitized system of record